EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN PATIENTS WITH POST-POLIO SYNDROME – AN UNCONTROLLED PILOT STUDY

Abstract

Data indicate that IVIg may have a clinically relevant effect, with an improvement in quality of life. The effect may be due to a decrease in an inflammatory process in the central nervous system, which earlier has been reported in patients with past-polio syndrome after IVIg treatment. Since a possible placebo effect cannot be ruled out, a randomized controlled study is needed.